# Motoko Unoki

Kyushu UniversityJapan

I identified several tumor suppressor candidates including EGR2, PINK1, and BPOZ when I was a graduate student in the University of Tokyo (Unoki et al., Oncogene, 2001, 2003), and identified UHRF1 as a novel methyl-CpG binding protein when I was a post doc in the University of Tokyo (Unoki et al., Oncogene, 2004). Then I worked on ING family splice variants when I was in NCI, NIH, Bethesda, MD, US (Unoki et al., JBC, 2006). Currently, my interest is to understand molecular pathogenesis of ICF syndrome (Unoki et al., JCI, 2019).

2chapters authored

View all Books